Oxford Nanopore Technologies (LON:ONT) Trading Down 7.8% – Time to Sell?

Shares of Oxford Nanopore Technologies plc (LON:ONT) were down 7.8% on Monday . The stock traded as low as GBX 131 ($1.64) and last traded at GBX 132 ($1.65). Approximately 3,102,731 shares were traded during mid-day trading, an increase of 42% from the average daily volume of 2,181,523 shares. The stock had previously closed at GBX 143.10 ($1.79).

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on ONT. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a GBX 190 ($2.38) price target on shares of Oxford Nanopore Technologies in a report on Wednesday, September 4th. Berenberg Bank reissued a “buy” rating and issued a GBX 282 ($3.54) target price on shares of Oxford Nanopore Technologies in a research report on Tuesday, September 3rd. Finally, JPMorgan Chase & Co. restated an “overweight” rating on shares of Oxford Nanopore Technologies in a report on Friday, December 6th. Five analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company has an average rating of “Buy” and an average price target of GBX 235.50 ($2.95).

Oxford Nanopore Technologies Stock Up 5.3 %

The company has a quick ratio of 6.01, a current ratio of 4.45 and a debt-to-equity ratio of 8.07. The business has a 50-day simple moving average of GBX 142.03 and a 200-day simple moving average of GBX 129.81. The stock has a market cap of £1.27 billion, a P/E ratio of -676.50 and a beta of 0.80.

Insider Buying and Selling

In related news, insider Gurdial (Gordon) Sanghera sold 1,993,571 shares of the stock in a transaction that occurred on Tuesday, October 15th. The stock was sold at an average price of GBX 142 ($1.78), for a total transaction of £2,830,870.82 ($3,548,791.30). In the last three months, insiders bought 310 shares of company stock valued at $45,010. Company insiders own 32.62% of the company’s stock.

Oxford Nanopore Technologies Company Profile

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific.